Agency Forms Undergoing Paperwork Reduction Act Review, 18853-18855 [2016-07424]
Download as PDF
<![CDATA[
18853
Federal Register / Vol. 81, No. 63 / Friday, April 1, 2016 / Notices
Gary
A. Kuiper or Manuel E. Cabeza, at the
FDIC address above.
SUPPLEMENTARY INFORMATION:
FOR FURTHER INFORMATION CONTACT:
Proposal to renew the following
currently-approved collections of
information:
1. Title: Foreign Banks.
OMB Number: 3064–0114.
Affected Public: Insured branches of
foreign banks.
Estimated Burden:
Number of
respondents
Reporting Burden
Moving a Branch ......................................................................................
Consent to Operate ..................................................................................
Conduct Activities .....................................................................................
Pledge of Assets Documents ...................................................................
Reports .....................................................................................................
Recordkeeping Burden ....................................................................................
Estimated Total Annual Burden:
1,314 hours.
General Description: The Foreign
Banks information collection, 3064–
0114, consist of: Applications to move
an insured state-licensed branch of a
foreign bank; applications to operate as
such noninsured state-licensed branch
of a foreign bank; applications from an
insured state-licensed branch of a
foreign bank to conduct activities that
are not permissible for a federallylicensed branch; internal recordkeeping
by such branches; and reporting and
recordkeeping requirements relating to
such a branch’s pledge of assets to the
FDIC.
Request for Comment
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Comments are invited on: (a) Whether
the collection of information is
necessary for the proper performance of
the FDIC’s functions, including whether
the information has practical utility; (b)
the accuracy of the estimates of the
burden of the information collection,
including the validity of the
methodology and assumptions used; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the information collection on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
All comments will become a matter of
public record.
Dated at Washington, DC, this 29th day of
March, 2016.
Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
[FR Doc. 2016–07403 Filed 3–31–16; 8:45 am]
BILLING CODE 6714–01–P
1
1
1
10
10
10
Jkt 238001
1
1
1
4
4
1
Burden hours
8
8
8
.25
2
120
8
8
8
10
80
1,200
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice to All Interested Parties of the
Termination of the Receivership of
10447, the Farmers Bank of
Lynchburg; Lynchburg, Tennessee
Centers for Disease Control and
Prevention
NOTICE IS HEREBY GIVEN that the
Federal Deposit Insurance Corporation
(‘‘FDIC’’) as Receiver for The Farmers
Bank of Lynchburg, Lynchburg,
Tennessee (‘‘the Receiver’’) intends to
terminate its receivership for said
institution. The FDIC was appointed
receiver of The Farmers Bank of
Lynchburg on June 15, 2012. The
liquidation of the receivership assets
has been completed. To the extent
permitted by available funds and in
accordance with law, the Receiver will
be making a final dividend payment to
proven creditors.
Based upon the foregoing, the
Receiver has determined that the
continued existence of the receivership
will serve no useful purpose.
Consequently, notice is given that the
receivership shall be terminated, to be
effective no sooner than thirty days after
the date of this Notice. If any person
wishes to comment concerning the
termination of the receivership, such
comment must be made in writing and
sent within thirty days of the date of
this Notice to: Federal Deposit
Insurance Corporation, Division of
Resolutions and Receiverships,
Attention: Receivership Oversight
Department 32.1, 1601 Bryan Street,
Dallas, TX 75201.
No comments concerning the
termination of this receivership will be
considered which are not sent within
this time frame.
Agency Forms Undergoing Paperwork
Reduction Act Review
Dated: March 29, 2016.
Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
BILLING CODE 6714–01–P
17:25 Mar 31, 2016
Hours per
response
FEDERAL DEPOSIT INSURANCE
CORPORATION
[FR Doc. 2016–07402 Filed 3–31–16; 8:45 am]
VerDate Sep<11>2014
Responses
per year
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
[30Day–15–15BFV]
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
E:\FR\FM\01APN1.SGM
01APN1
18854
Federal Register / Vol. 81, No. 63 / Friday, April 1, 2016 / Notices
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
A Study of Viral Persistence in Ebola
Virus Disease (EVD) Survivors—Existing
Information Collection Without an OMB
Control Number—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Much progress has been made in the
year since the CDC first responded to
the Ebola outbreak in West Africa, but
the agency’s efforts must continue until
there are zero new cases of Ebola virus
disease (EVD). As the CDC’s 2014 Ebola
virus response maintains the
international goal of zero new EVD
cases in 2015, the agency must intensify
its efforts to identify and prevent every
potential route of human disease
transmission and to understand the
most current community barriers to
reaching that final goal.
Persistence of Ebola Virus (EBOV) in
Body Fluids of EVD Survivors in Sierra
Leone is the first systematic
examination of the post-recovery
persistence of EBOV and the risks of
transmission from a cohort of
convalescent Ebola survivors during
close or intimate contact. It is important
to fully understand how long the virus
stays active in body fluids other than
blood in order to target and refine
public health interventions to arrest the
ongoing spread of disease.
The research study is comprised of
three modules based on the body fluids
to be studied: A pilot module of adult
males (semen) and two full modules:
Module A of adult men and women
repeating collections and questionnaires
every two weeks (semen, vaginal
secretions, and saliva, tears, sweat,
urine, rectal swab), and Module B of
lactating adult women repeating
collections and questionnaires every
three days (sweat and breast milk).
Participants for each module will be
recruited by trained study staff from
Ebola treatment units (ETUs) and
survivor registries. Participants will be
followed up at study sites in
government hospitals.
Specimens will be tested for EBOV
ribonucleic acid (RNA) by reverse
transcription polymerase chain reaction
test (RT–PCR) in Sierra Leone at the
CDC laboratory facility in Bo. All
positive RT–PCR samples will be sent to
CDC Atlanta for virus isolation. Each
body fluid will be collected until two
negative RT–PCR results are obtained.
Participants will be followed until all
their studied body fluids are negative.
They will receive tokens of appreciation
for their participation at the initial visit
and again at every subsequent follow-up
visit [e.g., 120,000 Leones
(approximately $28 US dollars) and a
supply of condoms]. For Module A, men
and women will be recruited in equal
numbers for this study until more
information on gender effects of viral
persistence is available. A trained study
data manager will collect test results for
all participants in a laboratory results
form.
Results and analyses are needed to
update relevant counseling messages
and recommendations from the Sierra
Leone Ministry of Health, World Health
Organization, and CDC. The study will
provide the most current information
that is critical to the development of
public health measures, such as
recommendations about sexual activity,
breastfeeding, and other routine
activities and approaches to evaluation
of survivors to determine whether they
can safely resume sexual activity. These
approaches in turn are expected to
reduce the risk of Ebola resurgence and
mitigate stigma for thousands of
survivors. The information is likewise
critical to reducing the risk that Ebola
would be introduced in a location that
has not previously been affected.
The total burden hours requested for
the research study in Sierra Leone is
2,474 hours incurred by 530
participants. There are no costs to the
respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Data Manager .................................................
Pilot participants ..............................................
Pilot participants ..............................................
Pilot participants ..............................................
Main study male participants ..........................
Main study male participants ..........................
Main study male participants ..........................
Main study female participants .......................
Main study female participants .......................
Main study female participants .......................
Data Manager .................................................
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Type of respondent
Intake Form ....................................................
Survivor Questionnaire ...................................
Survivor Follow-up Questionnaire ..................
3 & 6 Month Follow up Questionnaire ...........
Survivor Questionnaire ...................................
Survivor Follow-up Questionnaire ..................
3 & 6 Month Follow up Questionnaire ...........
Survivor Questionnaire ...................................
Survivor Follow-up Questionnaire ..................
3 & 6 Month Follow up Questionnaire ...........
Laboratory Results Form ...............................
1
100
100
100
120
120
120
120
120
120
1
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–07424 Filed 3–31–16; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
19:10 Mar 31, 2016
Jkt 238001
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
E:\FR\FM\01APN1.SGM
01APN1
Number of
responses per
respondent
550
1
5
2
1
12
2
1
4
2
4,250
Average
burden per
response
(hours)
20/60
30/60
15/60
15/60
30/60
15/60
15/60
30/60
15/60
15/60
10/60
Federal Register / Vol. 81, No. 63 / Friday, April 1, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Availability of the Final
Environmental Assessment (Final EA)
and a Finding of No Significant Impact
(FONSI) for HHS/CDC Fort Collins
Campus Proposed Improvements
Centers for Disease Control and
Prevention, Department of Health and
Human Services (HHS).
ACTION: Notice of Availability of Final
Environmental Assessment and a
Finding of No Significant Impact
(FONSI) for HHS/CDC Fort Collins
Campus Proposed Improvements.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), is issuing this notice to
advise the public that HHS/CDC has
prepared and approved on March 22,
2016, a Finding of No Significant Impact
(FONSI) based on the Final
Environmental Assessment for proposed
improvements on the HHS/CDC Fort
Collins Campus. HHS/CDC prepared the
Final EA in accordance with the
National Environmental Policy Act of
1969 (NEPA), as amended (42 U.S.C.
4321 et seq.), the Council on
Environmental Quality (CEQ)
implementing regulations (40 CFR parts
1500–1508) and the HHS General
Administration Manual (GAM) Part 30
Environmental Procedures, dated
February 25, 2000. HHS/CDC has
determined that the proposed action
would not have a significant impact on
the human or natural environment and
therefore, the preparation of an
Environmental Impact Statement is not
required.
DATES: The FONSI and Final EA are
available as of the publication date of
this notice.
ADDRESSES: Copies of the FONSI and
Final EA are available at the following
locations:
• Old Town Library, 201 Peterson
Street, Fort Collins, Colorado 80524.
• Harmony Library, 4616 South
Shields, Fort Collins, Colorado 80526.
Copies of the FONSI and/or Final EA
can also be requested from: Robert
Lawson, Centers for Disease Control and
Prevention, Asset Management Services
Office, MS K80, 1600 Clifton Road,
Atlanta, GA 30329, 770–488–2447.
SUPPLEMENTARY INFORMATION: The
Centers for Disease Control and
asabaliauskas on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:10 Mar 31, 2016
Jkt 238001
Prevention (CDC), an Operating Division
(OPDIV) of the Department of Health
and Human Services (HHS) has
prepared a Final EA to assess the
potential impacts associated with the
undertaking of proposed improvements
on the HHS/CDC Fort Collins Campus
(CDC Fort Collins Campus) located on
the Colorado State University (CSU)
Foothills Campus in Fort Collins,
Colorado. The Final EA analyzed the
effects of the Build Alternative
(Proposed Action) and the No Build
Alternative. The Build Alternative
consists of improvements to the CDC
Fort Collins Campus which entails the
construction of a new approximately
5,600 gsf building which will house
laboratory support freezer space and
communal space, upgrades to existing
parking areas and additional
infrastructure improvements. The No
Build Alternative represents the
continued operation of the existing
facilities at the CDC Fort Collins
Campus without any new construction
or infrastructure upgrades.
The Final EA evaluated the potential
impacts to socioeconomics and
environmental justice, land use, zoning,
public policy, community facilities and
services, transportation, air quality,
noise, cultural resources, urban design
and visual resources, natural resources,
utility service, hazardous materials,
greenhouse gases and sustainability, and
construction. HHS/CDC assessed the
potential impacts of the Build
Alternative in the Final EA and as a
result issued a FONSI indicating that
the proposed action will not have a
significant impact on the environment.
Dated: March 28, 2016.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
[FR Doc. 2016–07368 Filed 3–31–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10545, CMS–
10309, CMS–855(A, B, I) and CMS–10468]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
AGENCY:
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
ACTION:
18855
Notice.
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are require; to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
any of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
Comments must be received by
May 31, 2016.
DATES:
When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
ADDRESSES:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By Regular Mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number l, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
E:\FR\FM\01APN1.SGM
01APN1
]]>Agencies
[Federal Register Volume 81, Number 63 (Friday, April 1, 2016)]
[Notices]
[Pages 18853-18855]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07424]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-15-15BFV]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written
[[Page 18854]]
comments and/or suggestions regarding the items contained in this
notice should be directed to the Attention: CDC Desk Officer, Office of
Management and Budget, Washington, DC 20503 or by fax to (202) 395-
5806. Written comments should be received within 30 days of this
notice.
Proposed Project
A Study of Viral Persistence in Ebola Virus Disease (EVD)
Survivors--Existing Information Collection Without an OMB Control
Number--National Center for Emerging and Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Much progress has been made in the year since the CDC first
responded to the Ebola outbreak in West Africa, but the agency's
efforts must continue until there are zero new cases of Ebola virus
disease (EVD). As the CDC's 2014 Ebola virus response maintains the
international goal of zero new EVD cases in 2015, the agency must
intensify its efforts to identify and prevent every potential route of
human disease transmission and to understand the most current community
barriers to reaching that final goal.
Persistence of Ebola Virus (EBOV) in Body Fluids of EVD Survivors
in Sierra Leone is the first systematic examination of the post-
recovery persistence of EBOV and the risks of transmission from a
cohort of convalescent Ebola survivors during close or intimate
contact. It is important to fully understand how long the virus stays
active in body fluids other than blood in order to target and refine
public health interventions to arrest the ongoing spread of disease.
The research study is comprised of three modules based on the body
fluids to be studied: A pilot module of adult males (semen) and two
full modules: Module A of adult men and women repeating collections and
questionnaires every two weeks (semen, vaginal secretions, and saliva,
tears, sweat, urine, rectal swab), and Module B of lactating adult
women repeating collections and questionnaires every three days (sweat
and breast milk).
Participants for each module will be recruited by trained study
staff from Ebola treatment units (ETUs) and survivor registries.
Participants will be followed up at study sites in government
hospitals.
Specimens will be tested for EBOV ribonucleic acid (RNA) by reverse
transcription polymerase chain reaction test (RT-PCR) in Sierra Leone
at the CDC laboratory facility in Bo. All positive RT-PCR samples will
be sent to CDC Atlanta for virus isolation. Each body fluid will be
collected until two negative RT-PCR results are obtained. Participants
will be followed until all their studied body fluids are negative. They
will receive tokens of appreciation for their participation at the
initial visit and again at every subsequent follow-up visit [e.g.,
120,000 Leones (approximately $28 US dollars) and a supply of condoms].
For Module A, men and women will be recruited in equal numbers for this
study until more information on gender effects of viral persistence is
available. A trained study data manager will collect test results for
all participants in a laboratory results form.
Results and analyses are needed to update relevant counseling
messages and recommendations from the Sierra Leone Ministry of Health,
World Health Organization, and CDC. The study will provide the most
current information that is critical to the development of public
health measures, such as recommendations about sexual activity,
breastfeeding, and other routine activities and approaches to
evaluation of survivors to determine whether they can safely resume
sexual activity. These approaches in turn are expected to reduce the
risk of Ebola resurgence and mitigate stigma for thousands of
survivors. The information is likewise critical to reducing the risk
that Ebola would be introduced in a location that has not previously
been affected.
The total burden hours requested for the research study in Sierra
Leone is 2,474 hours incurred by 530 participants. There are no costs
to the respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (hours)
----------------------------------------------------------------------------------------------------------------
Data Manager.......................... Intake Form............. 1 550 20/60
Pilot participants.................... Survivor Questionnaire.. 100 1 30/60
Pilot participants.................... Survivor Follow-up 100 5 15/60
Questionnaire.
Pilot participants.................... 3 & 6 Month Follow up 100 2 15/60
Questionnaire.
Main study male participants.......... Survivor Questionnaire.. 120 1 30/60
Main study male participants.......... Survivor Follow-up 120 12 15/60
Questionnaire.
Main study male participants.......... 3 & 6 Month Follow up 120 2 15/60
Questionnaire.
Main study female participants........ Survivor Questionnaire.. 120 1 30/60
Main study female participants........ Survivor Follow-up 120 4 15/60
Questionnaire.
Main study female participants........ 3 & 6 Month Follow up 120 2 15/60
Questionnaire.
Data Manager.......................... Laboratory Results Form. 1 4,250 10/60
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-07424 Filed 3-31-16; 8:45 am]
BILLING CODE 4163-18-P
